241 related articles for article (PubMed ID: 1529414)
1. Raynaud's phenomenon as an early sign of connective tissue diseases.
Kallenberg CG
Vasa Suppl; 1992; 34():25-8. PubMed ID: 1529414
[TBL] [Abstract][Full Text] [Related]
2. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
Kallenberg CG
Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
[TBL] [Abstract][Full Text] [Related]
3. Need to expand microvascular investigation of patients with Raynaud's phenomenon of different etiology: clinical patterns of 106 consecutive patients.
Arpaia G; Cimminiello C; Bellone M; Aloisio M; Rossi F; Bonfardeci G
Int Angiol; 1994 Mar; 13(1):15-8. PubMed ID: 8077792
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon.
Wollersheim H; Thien T; Hoet MH; Van Venrooy WJ
Eur J Clin Invest; 1989 Dec; 19(6):535-41. PubMed ID: 2515974
[TBL] [Abstract][Full Text] [Related]
5. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
6. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
Navon P; Yarom A; Davis E
J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
[TBL] [Abstract][Full Text] [Related]
7. [Raynaud phenomenon in childhood: review and progress control in eight cases].
González Pascual E; Esquinas Rychen G; Ruiz España A; Ros Viladoms JB; Juanola Roura X
An Esp Pediatr; 1998 Jun; 48(6):603-7. PubMed ID: 9662844
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
[TBL] [Abstract][Full Text] [Related]
9. Raynaud's phenomenon.
Hughes M; Herrick AL
Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):112-32. PubMed ID: 27421220
[TBL] [Abstract][Full Text] [Related]
10. Raynaud's phenomenon: clinical spectrum of 118 patients.
De Angelis R; Del Medico P; Blasetti P; Cervini C
Clin Rheumatol; 2003 Oct; 22(4-5):279-84. PubMed ID: 14576990
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.
Houtman PM; Kallenberg CG; Fidler V; Wouda AA
J Rheumatol; 1986 Jun; 13(3):556-63. PubMed ID: 3735277
[TBL] [Abstract][Full Text] [Related]
12. The evolution of Raynaud's phenomenon: a longterm prospective study.
Luggen M; Belhorn L; Evans T; Fitzgerald O; Spencer-Green G
J Rheumatol; 1995 Dec; 22(12):2226-32. PubMed ID: 8835553
[TBL] [Abstract][Full Text] [Related]
13. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
[TBL] [Abstract][Full Text] [Related]
14. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.
Kallenberg CG; Wouda AA; Hoet MH; van Venrooij WJ
Ann Rheum Dis; 1988 Aug; 47(8):634-41. PubMed ID: 3261966
[TBL] [Abstract][Full Text] [Related]
15. [Raynaud's phenomenon and connective tissue diseases].
Guilmot JL; Diot E; Lasfargues G; Boissier C
Rev Prat; 1998 Oct; 48(15):1647-52. PubMed ID: 9814065
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of clinical signs and symptoms in patients with Raynaud's phenomenon. A cross-sectional study.
Wollersheim H; Thien T
Neth J Med; 1990 Dec; 37(5-6):171-82. PubMed ID: 2074908
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
Passiu G; Sebastiani GD; Galeazzi M; Tuveri MA; Nicosia PM; Boirivant R
Medicina (Firenze); 1990; 10(4):405-7. PubMed ID: 2099984
[TBL] [Abstract][Full Text] [Related]
18. Associations of nailfold capillary abnormalities and immunological markers in early Raynaud's phenomenon.
Schlager O; Kiener HP; Stein L; Hofkirchner J; Zehetmayer S; Ristl R; Perkmann T; Smolen JS; Koppensteiner R; Gschwandtner ME
Scand J Rheumatol; 2014; 43(3):226-33. PubMed ID: 24517537
[TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study.
Yunus MB; Hussey FX; Aldag JC
J Rheumatol; 1993 Sep; 20(9):1557-60. PubMed ID: 8164214
[TBL] [Abstract][Full Text] [Related]
20. [Raynaud's disease and Raynaud's phenomenon in connective tissue diseases].
Sicińska J; Rudnicka L
Pol Arch Med Wewn; 2002 Oct; 108(4):1011-22. PubMed ID: 12642947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
